Initial teacher training (ITT) providers are responsible for the management and administration of bursary payments, including assessment of eligibility. Trainees do not need to apply for a bursary and will automatically receive this from their ITT provider if eligible.<\/p>
The undergraduate veteran teaching bursary is paid over the final two years of the course, with £20,000 payable in each year. In the 2022/23 and 2023/24 academic years, five individual trainees received the undergraduate veteran teaching bursary, three of whom received a bursary in both years. Figures may be subject to change due to ongoing data collection and assurance.<\/p>
The department supports veterans into teaching in primary, secondary, and further education through its broad support services and bursaries. Since the publication of its commitments in the \u2018Veterans Strategy Action Plan 2022 to 2024\u2019, the department has tailored support and communications for the veteran community including dedicated teacher training advisers, webpages, case study blogs on the \u2018Get Into Teaching\u2019 website and information in Civvy Street publications. More information from Get Into Teaching is available here: https://getintoteaching.education.gov.uk/funding-and-support/if-youre-a-veteran<\/a> and here: https://getintoteaching.education.gov.uk/blog/from-the-army-to-teacher-training<\/a>. More information from Civvy Street can be found here: https://civvystreetmagazine.co.uk/2023/05/bring-your-unique-perspective-to-the-classroom-get-into-teaching-2/<\/a>.<\/p> Also available are bespoke webinars, and the opportunity to attend regional employer fairs with the Career Transition Partnership (CTP) and British Forces Resettlement Service (BFRS). More information about the CTP can be found here: https://www.ctp.org.uk/job-finding/directory/get-into-teaching<\/a>. More information about the BFRS can be found here: https://www.bfrss.org.uk/profiles/companies/986419/<\/a>.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3969", "label" : {"_value" : "Biography information for Damian Hinds"}
}
, "answeringMemberConstituency" : {"_value" : "East Hampshire"}
, "answeringMemberPrinted" : {"_value" : "Damian Hinds"}
, "dateOfAnswer" : {"_value" : "2024-04-17", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-17T12:07:05.757Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Teachers: Veterans"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, pursuant to the Answer of 15 March 2024 to Question 17304 on Teachers: Veterans, how many people applied for the undergraduate veteran teaching bursary in the academic years (a) 2022-23 and (b) 2023-24; and what steps he is taking to increase the number of undergraduate veteran teachers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "20858"}
, {"_about" : "http://data.parliament.uk/resources/1699966", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699966/answer", "answerText" : {"_value" : " FCDO Ministers will consider the UK position in advance of the upcoming election for the Secretary-General of the International Seabed Authority. The question of mineral-resources related activities in the seabed beyond the limits of national jurisdiction for the benefit of humankind is a critical one, and the outcome of this election will have wide significance.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1211", "label" : {"_value" : "Biography information for Mr Andrew Mitchell"}
}
, "answeringMemberConstituency" : {"_value" : "Sutton Coldfield"}
, "answeringMemberPrinted" : {"_value" : "Mr Andrew Mitchell"}
, "dateOfAnswer" : {"_value" : "2024-04-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-24T09:23:57.493Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "International Seabed Authority"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister of State, Foreign, Commonwealth and Development Office, whether he plans to support a third term for the Secretary-General of the International Seabed Authority.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1491", "label" : {"_value" : "Biography information for Kerry McCarthy"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol East"}
, "tablingMemberPrinted" : [{"_value" : "Kerry McCarthy"}
], "uin" : "20929"}
, {"_about" : "http://data.parliament.uk/resources/1699967", "AnsweringBody" : [{"_value" : "Department for Energy Security and Net Zero"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699967/answer", "answerText" : {"_value" : " In 2021, HMG consulted on current arrangements for trading electricity on power exchanges in the GB wholesale electricity market and outlined proposals to support efficient cross-border trading. That consultation focused on day-ahead trading but also sought views on the intraday timeframe.<\/p> <\/p> HMG\u2019s consultation response outlined the intention to legislate to achieve a single GB clearing price in the day-ahead timeframe, subject to engagement with the UK-EU Specialised Committee on Energy, industry and stakeholders to ensure HMG is well placed to make a final decision on progressing legislation. HMG confirmed development of efficient arrangements in other timeframes should remain under review.<\/p> <\/p> https://www.gov.uk/government/consultations/re-coupling-great-britain-electricity-auctions-for-cross-border-trade<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4601", "label" : {"_value" : "Biography information for Andrew Bowie"}
}
, "answeringMemberConstituency" : {"_value" : "West Aberdeenshire and Kincardine"}
, "answeringMemberPrinted" : {"_value" : "Andrew Bowie"}
, "dateOfAnswer" : {"_value" : "2024-04-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-18T05:58:51.28Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "215"}
, "answeringDeptShortName" : {"_value" : "Energy Security and Net Zero"}
, "answeringDeptSortName" : {"_value" : "Energy Security and Net Zero"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Electricity: Trade Competitiveness"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Energy Security and Net Zero, whether her Department has made an assessment of the potential impact of recoupling the GB and EU day-ahead electricity markets without recoupling the intraday markets on the competitiveness of wholesale electricity markets.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/62", "label" : {"_value" : "Biography information for Dr Alan Whitehead"}
}
, "tablingMemberConstituency" : {"_value" : "Southampton, Test"}
, "tablingMemberPrinted" : [{"_value" : "Dr Alan Whitehead"}
], "uin" : "20832"}
, {"_about" : "http://data.parliament.uk/resources/1699968", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699968/answer", "answerText" : {"_value" : " Through the medicine margin survey, the Department assesses whether the reimbursement arrangements pay pharmacy contractors as agreed as part of the community pharmacy contractual framework (CPCF). The medicine margin survey considers what pharmacies paid for medicines by looking at their invoices compared to the amount reimbursed by the National Health Service. Where the survey finds that they have been underpaid, we increase the pharmacy contractors\u2019 payments, and where they have been overpaid, we decrease payments.<\/p> Furthermore, where pharmacies cannot purchase products at or below the Drug Tariff NHS reimbursement price, Community Pharmacy England can request that the Department reassesses the reimbursement price. If a new reimbursement price is issued, this is known as a concessionary price.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-04-19", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "20979"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-19T09:54:36.01Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of medication costs on community pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "tablingMemberConstituency" : {"_value" : "Gosport"}
, "tablingMemberPrinted" : [{"_value" : "Dame Caroline Dinenage"}
], "uin" : "20988"}
, {"_about" : "http://data.parliament.uk/resources/1699969", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699969/answer", "answerText" : {"_value" : " As part of the Community Pharmacy Contractual Framework five-year deal, we committed £2.6 billion every year to community pharmacy, and agreed not to recover £212 million in over delivered fees and margin from community pharmacies in recent years. In addition, we are now investing up to £645 million across 2023/24 and 2024/25 in Pharmacy First, for more blood pressure checks and more contraception consultations in pharmacy. We have begun the consultation with Community Pharmacy England on the national funding and contractual framework arrangements for 2024/25.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4117", "label" : {"_value" : "Biography information for Andrea Leadsom"}
}
, "answeringMemberConstituency" : {"_value" : "South Northamptonshire"}
, "answeringMemberPrinted" : {"_value" : "Andrea Leadsom"}
, "dateOfAnswer" : {"_value" : "2024-04-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-18T16:00:23.64Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether she plans to increase core community pharmacy funding.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "tablingMemberConstituency" : {"_value" : "Gosport"}
, "tablingMemberPrinted" : [{"_value" : "Dame Caroline Dinenage"}
], "uin" : "20989"}
, {"_about" : "http://data.parliament.uk/resources/1699970", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699970/answer", "answerText" : {"_value" : " Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service, and keep the conditions covered by Pharmacy First under review.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4117", "label" : {"_value" : "Biography information for Andrea Leadsom"}
}
, "answeringMemberConstituency" : {"_value" : "South Northamptonshire"}
, "answeringMemberPrinted" : {"_value" : "Andrea Leadsom"}
, "dateOfAnswer" : {"_value" : "2024-04-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-18T16:57:21.523Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether she plans to increase the scope of the Pharmacy First programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "tablingMemberConstituency" : {"_value" : "Gosport"}
, "tablingMemberPrinted" : [{"_value" : "Dame Caroline Dinenage"}
], "uin" : "20990"}
, {"_about" : "http://data.parliament.uk/resources/1699971", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699971/answer", "answerText" : {"_value" : " The Priority Review programme is not currently planned, but the Government is taking other significant steps for medical device regulatory reform, as part of a broader Medical Technology Strategy. Further information on the Medical Technology Strategy is available at the following link:<\/p> <\/p> https://www.gov.uk/government/publications/medical-technology-strategy/medical-technology-strategy<\/a><\/p> <\/p> The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medical devices, and designates United Kingdom Approved Bodies to conduct conformity assessments against the relevant regulatory requirements. The MHRA works closely with Approved Bodies to ensure their timely assessment.<\/p> <\/p> Following a consultation on the future regulation of medical devices in 2021, the MHRA is leading a programme of work to introduce updated regulations for medical devices that prioritise patient safety, improve patient access to innovative medical devices, and ensure the UK remains an attractive market for medical technology innovators. In January of this year, the MHRA published a MedTech Regulatory roadmap that sets out the main activities in implementing the future regulations throughout 2024 and 2025. An international recognition framework for medical devices will form part of the future regulatory framework, which will provide an alternative route to the UK\u2019s market, by leveraging approvals from comparable international regulators. The MHRA aims to publish an outline of the International Recognition Framework for medical devices later this spring, aligned to the Life Sciences Council, subject to necessary approvals.<\/p> In addition, the MHRA is leading the reform of the medical devices regulatory landscape and includes a new pathway to accelerate access to safe, innovative medical devices to help meet the unmet needs of patients. The Innovative Devices Access Pathway aims to bring new medical technologies and solutions to the National Health Service, to support the medical needs that are not currently being met. There are eight innovative medical technologies included in the pilot phase.<\/p> We are working alongside others to further the Life Sciences Vision, particularly improving regulation and regulatory processes around medical devices, and supporting broader ambitions in the vision aligned to the conditions set out in the Major Conditions Strategy. As we work to update the medical devices regulatory landscape, the MHRA is taking the Major Conditions Strategy into consideration, including the six groups of major health conditions.<\/p> The National Institute for Health and Care Excellence (NICE) is not a regulator but makes recommendations for the NHS on whether selected medical devices should be routinely adopted by the NHS, based on an assessment of their costs and benefits. Medical devices are prioritised for the NICE\u2019s evaluation, in line with NICE\u2019s published topic selection manual.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-04-22", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "20992"}
, {"_value" : "20993"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-22T11:22:39.867Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Equipment"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether she plans to develop a Priority Review programme for medical devices.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "tablingMemberConstituency" : {"_value" : "Gosport"}
, "tablingMemberPrinted" : [{"_value" : "Dame Caroline Dinenage"}
], "uin" : "20991"}
, {"_about" : "http://data.parliament.uk/resources/1699972", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1699972/answer", "answerText" : {"_value" : " The Priority Review programme is not currently planned, but the Government is taking other significant steps for medical device regulatory reform, as part of a broader Medical Technology Strategy. Further information on the Medical Technology Strategy is available at the following link:<\/p> <\/p>